SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Zonagen (zona) - good buy?

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Peter Kerling who wrote (5130)8/6/1998 1:03:00 AM
From: S. maltophilia  Read Replies (2) of 7041
 
<<Do you know, what Biotech funds are invested in ZONA? What will
happen if just one manager gets cold feet say's 'good bye' to
ZONA?!>>

Here's the major owners from DEF14A 4/30/98:
sec.gov

T. Rowe Price Associates, Inc. 1,069,900 8.99%
100 E. Pratt Street
Baltimore, MD 21202
Capital Research & Management 932,000 7.83%
333 South Hope Street
Los Angeles, CA 90071
Franklin Advisers, Inc. 803,000 6.75%
777 Mariners Island Blvd.
San Mateo, CA 94404
Petrus Fund, L.P. 755,793 6.35%
12377 Merit Dr., Suite 1700
Dallas, TX 75251
Martin P. Sutter 303,939 /(3)/ 2.55%
Joseph S. Podolski 143,070 /(4)/ 1.20%
David Bowman 21,169 /(5)/ *
Steven Blasnik 775,168 /(6)/ 6.51%
Tommy L. Lee 13,000 /(7)/ *
Timothy McInerney 90,810 /(8)/ *
David B. McWilliams 45,549 /(9)/ *
Louis Ploth 27,700 /(10)/ *
All directors and executive officers 1,420,405 /(3)-(10)/ 11.93%
as a group (8 persons)

Capital research is American Funds. Petrus appears to be a venture capital outfit linked to Perot. The only reference I find is this from Asensio: asensio.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext